ArticleNeuro-oncology practice2019

Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burden.

Huy Tram Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.